Reditus Laboratories

To accommodate their growing operations, Reditus Laboratories underwent a substantial expansion in March 2021, enlarging their laboratory space from 2500 sq. ft. to over 23,000 sq. ft. This expansion enabled the company to offer anatomic pathology services, which facilitated the diagnosis of soft tissue and wound infections for a wide range of healthcare providers. Reditus rapidly emerged as a national leader in Covid testing services, having successfully processed over 3.3 million tests and counting. Their laboratory became renowned for providing comprehensive turnkey solutions to schools, universities, and private industries. Reditus offered on-site training for Covid testing at educational institutions and provided the necessary staff, testing supplies, and kits. Their efforts played a vital role in keeping schools open and ensuring children's health during the worldwide pandemic. With the capacity to run 100,000 tests daily, the company also extended their testing services to government organizations, employing the ThermoFisher EUA PCR High-throughput testing platform. The company supplied complete test collection kits, including sterile nasal swabs, transport tubes, and viral collection media, ensuring efficient and accurate testing processes. The operational efficiency demonstrated by Reditus during its initial years stands as a testament to the exceptional leadership that founded the company. Through the provision of essential personal protective equipment, such as glasses, gowns, and masks, and the accurate testing conducted on a significant portion of the local and national population, Reditus significantly reduced the spread of Covid. Even before gaining nationwide attention due to the Covid pandemic, Reditus had already established itself as a premier testing lab for podiatry. Furthermore, the company has expanded into urology and histology testing. Histology tests are crucial in helping doctors diagnose abnormalities in human cells or tissue.